Curaleaf Holdings (CURLF) FCF Margin Growth (3y) (2022 - 2024)
Curaleaf Holdings (CURLF) FCF Margin Growth (3y) (2022 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,783.00 |
| Sep 30, 2024 | -900.00 |
| Jun 30, 2024 | -1.28 Mn |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | 828.00 |
| Jun 30, 2023 | -240,125.00 |
| Dec 31, 2022 | 22,878.00 |
| Sep 30, 2022 | 1,355.00 |